Trial record 1 of 1 for:    20547525 [PUBMED-IDS]
Previous Study | Return to List | Next Study

Increasing Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00212914
Recruitment Status : Completed
First Posted : September 21, 2005
Last Update Posted : September 9, 2008
Canadian Institutes of Health Research (CIHR)
Information provided by:
Ottawa Hospital Research Institute

Brief Summary:
In 1998, The Canadian Diabetes Association published guidelines that recommended women diagnosed with gestational diabetes mellitus (GDM,) should be screened postpartum for Type 2 diabetes using a glucose tolerance test. We determined the rate of screening for Type 2 diabetes at the Ottawa Hospital before and after the publication of this guideline and found that none of the women in either period had been screened following this recommendation. We believe a reminder letter outlining the recommended screening test sent to the patient and/or her family physician would increase screening for Type 2 diabetes in women with previous GDM.

Condition or disease Intervention/treatment Phase
Gestational Diabetes Behavioral: Reminder letter Not Applicable

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Enrollment : 268 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Official Title: Mailing Recommendations to the Individual or Physician to Increase Screening for Type 2 Diabetes in Women With Previous Gestational Diabetes: Clinical Trial.
Study Start Date : May 2002
Study Completion Date : January 2006

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. The proportion of patients screened in each group

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • All women, who are pregnant and attend the High Risk Pregnancy Unit and who have been diagnosed with Gestational Diabetes will be considered for inclusion in the study.

Exclusion Criteria:

  • 1. Patient does not have a Family Physician 2. Patient's Family Physician already has a patient enrolled in the study 3. Patient already enrolled in the study for a previous pregnancy 4. Unable to give informed consent in English or French 5. History of pre-gestational diabetes mellitus 6. Intra-uterine fetal death or still birth

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00212914

Canada, Ontario
The Ottawa Hospital, Civic Campus, High Risk Unit
Ottawa, Ontario, Canada, K1Y 1J7
Sponsors and Collaborators
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)
Principal Investigator: Heather Clark, MD OHRI

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00212914     History of Changes
Other Study ID Numbers: CIHR- KTE 110023
First Posted: September 21, 2005    Key Record Dates
Last Update Posted: September 9, 2008
Last Verified: September 2008

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications